Now showing items 1-1 of 1

    • Thumbnail

      Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status 

      Manka, Paul; Sydor, Svenja; Wase, Nishikant; Best, Jan; Brandenburg, Malte; Hellbeck, Annika; Schänzer, Julia; Vilchez-Vargas, Ramiro; Link, Alexander; Figge, Anja; Jähnert, Andreas; Von Arnim, Ulrike; Coombes, Jason D.; Cubero, Francisco-Javier; Kahraman, Alisan; Kim, Moon-Sung; Kälsch, Julia; Kinner, Sonja; Faber, Klaas-Nico; Moshage, Han; Gerken, Guido; Syn, Wing-Kin; Friedman, Scott L.; Canbay, Ali; Bechmann, Lars P. (Wiley, 2021-11)
      Background and Aims An association between Crohn's disease (CD) and hepatic steatosis has been reported. However, the underlying mechanisms of steatosis progression in CD are not clear. Among the most effective CD treatments ...